Degree-Based Molecular Descriptors and QSPR Analysis of Breast Cancer Drugs

Table 2

Physicochemical properties of breast cancer drugs.

SI no	Drug name	BP	EV	FP	MR	LogP	MV
1	Alpelisib	—	—	—	106.7	−0.02	317.4
2	Azacitidine	534.5	93.2	277	51.1	−1.99	117.1
3	Cytarabine	545.7	94.8	283.8	52.6	−1.93	128.4
4	Daunorubicin	770	117.6	419.5	130	2.92	339.4
5	Dexamethasone	568.2	98	297.5	100.2	1.87	296.2
6	Docetaxel	900.5	137.1	498.4	205.2	6.55	585.7
7	Doxorubicin	810.3	123.5	443.8	131.5	2.82	336.6
8	Glasdegib	633.4	93.6	336.9	106.9	2.77	281
9	Gilteritinib	696.9	102.1	375.3	157.8	4.35	444.9
10	Ivosidenib	854.3	124.1	470	140.1	0.38	383.6
11	Midostaurin	—	—	—	160.3	5.27	385.7
12	Olaparib	—	—	—	116.9	0	301.8
13	Paclitaxel	957.1	146	532.6	219.3	7.38	610.6
14	Palbociclib	711.5	104	384.1	123.9	0.99	340.7
15	Pamidronic acid	658.7	111	352.2	40.9	−3.4	117.6
16	Prednisone	573.7	98.7	314.8	94.1	1.57	273.6
17	Ribociclib	730.8	106.7	395.8	123.4	−0.74	311.4
18	Tioguanine	460.7	72.1	232.4	41.9	−0.99	80.2
19	Toremifene	535.1	81.2	277.4	123.7	7.82	367.6
20	Tucatinib	—	—	—	135.2	3.62	339
21	Venetoclax	—	—	—	234.4	10.88	647.7